CtrlK
Amgen
AMGN59
$303.77arrow_drop_down0.62%-$1.92
NASDAQ - As of Apr 3, 5:15 AM EDT Market Closed
S&P500
AMGN59
$303.77
arrow_drop_down0.62%Performance History
arrow_drop_up14.02%
(+$37.61 )
| Key Stats | |
|---|---|
| Open | $306.83 |
| Prev. Close | $305.70 |
| EPS | 7.55 |
| Dividend | $9.13 |
| Next Earnings Date | Jun 3, 2025 |
| Dividend Yield % | 3.09% |
| Market Cap | $163.98B |
| PE Ratio | 40.24 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 301.53 | 306.83 |
| 52 Week Range | 249.70 | 346.85 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Correlated Companies
About Amgen (AMGN)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—General
- CEO
- Mr. Robert A. Bradway
- Headquarters
- Thousand Oaks
- Employees
- 25200
- Exchange
- NASDAQ
Keep an eye on Amgen
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the 52-week high and low for Amgen (AMGN)?
For Amgen (AMGN), the 52-week high is $346.85, which is 14.18% from the current price. The 52-week low is $249.7, the current price is 21.66% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
What is Amgen 's (AMGN) price per share?
The current price per share for Amgen (AMGN) is $303.77. The stock has seen a price change of -$1.93 recently, indicating a -0.63% change. This reflects the stock's recent market performance and investor sentiment.
help
Is Amgen (AMGN) a growth stock?
Amgen (AMGN) has shown an average price growth of -1.65% over the past three years. It has received a score of 66 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Amgen as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Amgen (AMGN) stock price performance year to date (YTD)?
As of the latest data, Amgen (AMGN) has a year-to-date price change of 16.55%. Over the past month, the stock has experienced a price change of -2.25%. Over the last three months, the change has been 17.16%. Over the past six months, the figure is -4.99%. Looking at a longer horizon, the five-year price change stands at 45.43%.
help
Is Amgen (AMGN) a profitable company?
Amgen (AMGN) has a net income of $4.09B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 61.53% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 51.81% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $33.42B, with a revenue growth rate of 18.57%, providing insight into the company's sales performance and growth. The gross profit is $20.57B. Operating income is noted at $7.26B. Furthermore, the EBITDA is $13.36B.
help
What is the market capitalization of Amgen (AMGN)?
Amgen (AMGN) has a market capitalization of $163.99B. The average daily trading volume is 304.11, indicating the stock's liquidity and investor engagement.